Forte Biosciences (FBRX) Short Interest Ratio & Short Volume → I’m afraid WWIII is a very real possibility (From Porter & Company) (Ad) Free FBRX Stock Alerts $0.60 -0.03 (-4.75%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Forte Biosciences Short Interest DataCurrent Short Volume28,800 sharesPrevious Short Volume33,000 sharesChange Vs. Previous Month-12.73%Dollar Volume Sold Short$21,052.80Short Interest Ratio / Days to Cover1.0Last Record DateApril 30, 2024Outstanding Shares36,440,000 sharesPercentage of Shares Shorted0.08%Today's Trading Volume32,499 sharesAverage Trading Volume14,966 sharesToday's Volume Vs. Average217% Short Selling Forte Biosciences ? Sign up to receive the latest short interest report for Forte Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFBRX Short Interest Over TimeFBRX Days to Cover Over TimeFBRX Percentage of Float Shorted Over Time Ad Porter & CompanyI’m afraid WWIII is a very real possibility As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film.Take a look. Forte Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202428,800 shares $21,052.80 -12.7%N/A1 $0.73 4/15/202433,000 shares $23,430.00 -3.2%N/A1 $0.71 3/31/202434,100 shares $23,740.42 -19.2%N/A1 $0.70 3/15/202442,200 shares $26,164.00 -36.6%N/A1.2 $0.62 2/29/202466,600 shares $45,474.48 -17.2%N/A1.6 $0.68 2/15/202480,400 shares $55,910.16 +62.4%N/A2.1 $0.70 Get the Latest News and Ratings for FBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Forte Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/202449,500 shares $30,199.95 -28.7%N/A1.1 $0.61 1/15/202469,400 shares $51,356.00 -55.4%N/A1.8 $0.74 12/31/2023155,500 shares $127,774.35 +57.1%N/A3.9 $0.82 12/15/202399,000 shares $74,250.00 +40.4%N/A2.5 $0.75 11/30/202370,500 shares $33,417.00 +21.6%N/A1.7 $0.47 11/15/202358,000 shares $22,045.80 +3.2%N/A1.5 $0.38 10/31/202356,200 shares $27,594.20 -2.9%N/A1.8 $0.49 10/15/202357,900 shares $33,020.37 -10.9%N/A0.7 $0.57 9/30/202365,000 shares $43,030.00 -0.8%N/A0.8 $0.66 9/15/202365,500 shares $53,683.80 -1.8%N/A0.8 $0.82 8/31/202366,700 shares $55,367.67 -7.6%N/A0.8 $0.83 8/15/202372,200 shares $59,204.00 +38.3%N/A0.9 $0.82 7/31/202352,200 shares $52,722.00 -7.6%N/A0.7 $1.01 7/15/202356,500 shares $56,500.00 -0.9%N/A1.8 $1.00 6/30/202357,000 shares $59,280.00 +4.8%N/A0.9 $1.04 6/15/202354,400 shares $56,032.00 +0.4%N/A0.9 $1.03 5/31/202354,200 shares $55,284.00 -4.1%N/A0.8 $1.02 5/15/202356,500 shares $61,076.50 -15.7%N/A0.8 $1.08 4/30/202367,000 shares $71,690.00 -42.4%N/A1 $1.07 4/15/2023116,400 shares $125,712.00 +203.9%N/A1.7 $1.08 3/31/202338,300 shares $38,683.00 -27.3%N/A0.6 $1.01 3/15/202352,700 shares $51,999.09 -23.0%N/A1.3 $0.99 2/28/202368,400 shares $69,768.00 +0.4%N/A1.7 $1.02 2/15/202368,100 shares $68,100.00 -2.4%N/A1.7 $1.00 1/31/202369,800 shares $69,800.00 +0.7%N/A1.7 $1.00 1/15/202369,300 shares $70,686.00 -39.5%N/A1.7 $1.02 12/30/2022114,500 shares $114,500.00 +36.8%N/A2.8 $1.00 12/15/202283,700 shares $85,374.00 -16.3%N/A2.1 $1.02 11/30/2022100,000 shares $99,480.00 -19.4%N/A1.9 $0.99 11/15/2022124,100 shares $124,100.00 +17.1%N/A1.9 $1.00 10/31/2022106,000 shares $114,480.00 +1.7%N/A1.2 $1.08 10/15/2022104,200 shares $107,326.00 -10.8%N/A0.7 $1.03 9/30/2022116,800 shares $124,976.00 +8.4%N/A0.6 $1.07 9/15/2022107,800 shares $137,984.00 -2.3%N/A0.4 $1.28I’m afraid WWIII is a very real possibility (Ad)As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film.Take a look. FBRX Short Interest - Frequently Asked Questions What is Forte Biosciences' current short interest? Short interest is the volume of Forte Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 28,800 shares of FBRX short. Learn More on Forte Biosciences' current short interest. What is a good short interest ratio for Forte Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FBRX shares currently have a short interest ratio of 1.0. Learn More on Forte Biosciences's short interest ratio. Is Forte Biosciences' short interest increasing or decreasing? Forte Biosciences saw a decrease in short interest in April. As of April 30th, there was short interest totaling 28,800 shares, a decrease of 12.7% from the previous total of 33,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Forte Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Forte Biosciences: Iterum Therapeutics plc (7.68%), Lisata Therapeutics, Inc. (0.22%), RenovoRx, Inc. (0.19%), Oncternal Therapeutics, Inc. (0.49%), Unity Biotechnology, Inc. (2.16%), Aptorum Group Limited (0.50%), TherapeuticsMD, Inc. (0.46%), Acasti Pharma Inc. (0.02%), Biora Therapeutics, Inc. (4.52%), Bullfrog AI Holdings, Inc. (3.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Forte Biosciences stock? Short selling FBRX is an investing strategy that aims to generate trading profit from Forte Biosciences as its price is falling. FBRX shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Forte Biosciences? A short squeeze for Forte Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FBRX, which in turn drives the price of the stock up even further. How often is Forte Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Iterum Therapeutics Short Squeeze Lisata Therapeutics Short Squeeze RenovoRx Short Squeeze Oncternal Therapeutics Short Squeeze Unity Biotechnology Short Squeeze Aptorum Group Short Squeeze TherapeuticsMD Short Squeeze Acasti Pharma Short Squeeze Biora Therapeutics Short Squeeze Bullfrog AI Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FBRX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetry